Information Provided By: 
Fly News Breaks for January 24, 2017
ONVO
Jan 24, 2017 | 16:12 EDT
Raymond James analyst Reni Benjamin initaited Organovo with an Outperform and a $5 price target. The analyst said Organovo is at the early stages of exploring the potential of 3D printed tissue in a variety of therapeutic approaches, including the development of an organ patch for patients with liver injury and has secured 10 of the 25 big pharma as corporate partners in evaluating a variety of drug products including Roche, Merck, Bristol-Myers, and Astellas.
News For ONVO From the Last 2 Days
There are no results for your query ONVO
